category
Unassigned
,
Gold & Silver
from Trefis
category
Pharmaceuticals
,
Unassigned
from Trefis
category
Pharmaceuticals
,
Unassigned
from Trefis
from Trefis
Roche Earnings Preview: What We Are Watching
April 08, 2013
category
Pharmaceuticals
,
Unassigned
from Trefis
100 Guru Stock Buy List | The Most Bought Stocks
April 03, 2013
from Trefis
Warren Buffett’s Best Yielding Dividend Stocks
March 19, 2013
category
Unassigned
,
Oil & Gas
from Trefis
category
Unassigned
,
Internet
from Trefis
10 Best Dividend Paying Drug Manufacturing Stocks
March 05, 2013
category
Pharmaceuticals
,
Unassigned
from Trefis
Here’s What Matters For Baidu’s $115 Valuation
March 01, 2013
category
Unassigned
,
Internet
from Trefis
Heinz Savors Emerging Markets Growth And Reaffirms Brand Strength
February 22, 2013
from Trefis
Pozen: An Undervalued Investment And Catalyst Trade Opportunity
February 11, 2013
category
Pharmaceuticals
,
Unassigned
from Trefis
category
Pharmaceuticals
,
Unassigned
from Trefis
Plavix Patent Cliff Will Impact Bristol-Myers’ Earnings
January 23, 2013
category
Pharmaceuticals
,
Unassigned
from Trefis
The 3 Best Yielding Top Stocks From Ken Fisher’s Q3/2012 Fund Portfolio
December 28, 2012
from Trefis
Zacks Analyst Jason Napodano’s Seven Biotech Picks Will Keep Your Profits on Solid Ground
December 13, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
Warren Buffett’s Best Yielding Dividend Stocks
December 05, 2012
category
Unassigned
,
Oil & Gas
from Trefis
category
Pharmaceuticals
,
Unassigned
from Trefis
Applying the Venture Capital Model to Public Companies: Hugh Cleland
November 28, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
category
Pharmaceuticals
,
Unassigned
from Trefis
Wednesday’s Bio-Pharma Catalyst Trades And Watch List
November 21, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
category
Pharmaceuticals
,
Unassigned
from Trefis
Is There Big Value In Addiction Fighting Pharmas?
November 15, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
Upcoming BioPharma Catalyst Trades to Consider
November 13, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
Boston Scientific Acquires Vessix Vascular To Bolster Peripheral Intervention Business
November 09, 2012
from Trefis
from Trefis
Why Teva Pharmaceutical Is An Attractive Buying Opportunity
November 06, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
Emerging Market Health Care: Prognosis Profitable
October 11, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
Pfizer’s $26 Value Finds Support With Strong Prevnar Vaccine Outlook
October 09, 2012
category
Pharmaceuticals
,
Unassigned
from Trefis
Boston Scientific Acquires BridgePoint Medical To Bolster Interventional Cardiology Business
September 21, 2012
from Trefis
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

